Degron-independent recruitment of KAT2A expands the target space of CRBN molecular glues
Samuel Ojeda1,2, Meng Wang1,2, Kheewoong Baek1,2
1Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
Abstract:
Lysine acetyltransferases (KATs) cooperate with oncogenes such as c-Myc, estrogen receptor, and lysine methyltransferase 2A (KMT2A) fusions to sustain malignant programs. Targeting of KAT proteins has shown clinical efficacy; however, achieving homolog selectivity for most KATs remains a major challenge. By extending cereblon (CRBN)-based molecular glues beyond the canonical degron space, we developed an exquisitely selective degrader of KAT2A. Cryo-electron microscopy revealed that CRBN recruits KAT2A independently of a degron; instead, the molecular glue engages a surface-exposed tyrosine, mimicking antibody-like molecular recognition. Selective KAT2A degradation leads to potent ablation of histone H3 lysine 9 acetylation (H3K9Ac), antiproliferative effects in acute myeloid leukemia cell lines, and in vivo efficacy in a patient-derived xenograft model, establishing KAT2A as a targetable vulnerability to treat a wide range of malignancies. More generally, degron-independent recruitment extends the CRBN-targetable proteome.
Insights
Researchers developed a selective molecular glue to degrade KAT2A, a protein cooperating with oncogenes. This approach shows promise for treating cancers like acute myeloid leukemia by targeting KAT2A's vulnerability.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Lysine acetyltransferases (KATs) are crucial in sustaining cancer cell programs by cooperating with oncogenes.
- Targeting KAT proteins offers clinical efficacy, but achieving selectivity among KAT homologs is challenging.
Purpose of the Study:
- To develop a highly selective KAT2A degrader by extending cereblon (CRBN)-based molecular glues.
- To investigate the mechanism of CRBN-mediated KAT2A recruitment and its therapeutic potential.
Main Methods:
- Development of novel cereblon (CRBN)-based molecular glues.
- Cryo-electron microscopy to elucidate the CRBN-KAT2A interaction.
- Assessment of KAT2A degradation, histone acetylation, and antiproliferative effects in cell lines and patient-derived xenografts.
Main Results:
- Developed a molecular glue achieving exquisite selectivity for KAT2A degradation.
- Cryo-EM revealed a novel, degron-independent recruitment mechanism involving a surface-exposed tyrosine.
- Selective KAT2A degradation effectively reduced H3K9Ac, inhibited proliferation in AML cells, and showed in vivo efficacy.
Conclusions:
- KAT2A is a targetable vulnerability in various malignancies.
- Degron-independent recruitment expands the scope of CRBN-targetable proteins.
- This strategy offers a new therapeutic avenue for cancers driven by KAT proteins.
Related Concept Videos
Receptor Tyrosine Kinases
Intracellular Signaling Affects Focal Adhesions
Some...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:


